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ABSTRACT
Functionalized carbon nanotubes have already demonstrated great biocompatibility and potential for drug 
delivery. We have synthesized acid oxidized and non-covalently PEGlyated single-walled carbon nanotubes 
(SWNTs), which were previously prepared for drug delivery purposes, and explored their potential for 
detoxifi cation in the bloodstream. Our investigations of the binding of SWNTs to a pore-forming toxin pyolysin 
show that SWNTs prevented toxin-induced pore formation in the cell membrane of human red blood cells. 
Quantitative hemolysis assay and scanning electron microscopy were used to evaluate the inhibition of 
hemolytic activity of pyolysin. According to Raman spectroscopy data, human red blood cells, unlike HeLa 
cells, did not internalize oxidized SWNTs. Molecular modeling and circular dichroism measurements were 
used to predict the 3-D structure of pyolysin (domain 4) and its interaction with SWNTs. The tryptophan-rich 
hydrophobic motif in the membrane-binding domain of pyolysin, a common construct in a large family of 
cholesterol-dependent cytolysins, shows high affi nity for SWNTs.
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Introduction
Intoxication resulting from drug overdose, accidental 
exposure to toxic compounds, and bacterial toxins 
accounts for a signifi cant number of deaths each year 
[1]. In many cases, antidotes are not available and 
detoxifi cation procedures are largely based on general 
measures to clear the toxic agents out of the body. 
One example is hemodialysis (passing the blood 
through a bedside dialysis machine) for eliminating 
life-threatening toxins. A recently proposed strategy is 
to administer injectable nanocarriers as high capacity 
sinks for toxins in the blood [2]. Although substantial 
effort has been devoted to the development of 
nanoparticulate drug carriers, few reports of nano-
detoxifi cation systems can be found. Here, we report 
a pilot study of the development of carbon nanotube 
(CNT) carriers for biodetoxification. Functionalized 
single-walled carbon nanotubes (SWNTs) have been 
demonstrated to have great potential for targeted 
delivery of therapeutic compounds and diagnostic 
agents [3 6]. In general, systems for biodetoxifi cation 
and drug delivery share similar characteristics (e.g., 
innocuousness, physical size, blood circulation time, 
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loading capacity), but with distinctively different 
design goals and end points for performance 
evaluation. Instead of delivering therapeutic agents 
to targeted cells or tissues, biodetoxifi ers commonly 
aim at rapid inactivation and clearance of toxic agents 
from the blood stream. In this study, we evaluate the 
potential of oxidized SWNTs as detoxifiers in the 
blood against pore-forming toxins (PFTs).
PFTs are mostly produced by pathogenic bacteria 
as water-soluble proteins destined to form pores in 
the lipid membranes of the host organism, which 
may lead directly or indirectly to the pathogenesis 
of acute and chronic diseases. Pore formation on 
cell membranes by PFTs is a major mechanism by 
which pathogenic bacteria cause host cell destruction 
and acquire nutrients from damaged cells essential 
for their survival [7].  In this study, we used 
pyolysin (PLO), an important virulence factor of 
Arcanobacterium pyogenes, as a model PFT [8]. PLO is 
a hemolysin and belongs to the family of cholesterol-
dependent cytolysins (CDCs), which comprises 
toxins produced by more than twenty species of 
gram-positive bacteria.
1. Results and discussion
1.1 Preparation of SWNT aqueous solution
Two types of water soluble SWNTs were prepared, 
namely, acid oxidized SWNTs (SWNT-OXs) and 
phospholipid polyethylene glycol  (PL-PEG) 
suspended SWNTs (SWNT-PEGs) (see Methods 
section). SWNT-OX and SWNT-PEG have very 
similar physical dimensions, being ~2 nm in diameter 
and less than 500 nm in length [3]. SWNT-OXs have 
sidewalls and ends decorated with carboxylic groups 
( COOH) and are therefore negatively charged at 
physiological pH [10]. SWNT-PEG is neutral and 
more hydrophilic due to the packing of long PEG 
chains with methoxy ( OCH3) terminal groups on 
the SWNT sidewalls. The results presented in the 
main text are solely from SWNT-OX. Experimental 
results for SWNT-PEG are available in the Electronic 
Supplementary Material (ESM) which demonstrate 
the generality of water soluble SWNTs as detoxifi ers 
regardless of differences in surface functionalization.
 
1.2   Inhibition of hemolytic activity of PLO by 
SWNT-OX
A quantitative microtiter plate hemolysis assay [11] 
was used to characterize the hemolytic activity of 
PLO with and without SWNT-OX. The decrease in 
turbidity, i.e., optical density at 650 nm (OD650), is 
directly correlated to lysis of human red blood cells 
(RBCs) [11]. The results were normalized and are 
shown in Fig. 1. For RBCs exposed to 20 nmol/L PLO 
(no SWNT-OX), OD650 declined rapidly to a baseline 
level, indicating complete lysis of RBCs in about 10 
min. In the presence of SWNT-OX, hemolytic activity 
of PLO was inhibited in a concentration dependent 
fashion. With 10 nmol/L SWNT-OX in PBS buffer, 
OD650 remained almost constant over the period of 
observation (2 h), which suggests nearly complete 
inhibition of hemolysis (Fig. 1(a)). SWNT-OX alone 
did not cause any cell lysis (the data were identical 
to those from control RBCs). Furthermore, hemolysis 
assay was performed in 1 × fetal bovine serum (FBS) 
(Fig. 1(b)), where serum proteins are present at 
concentrations four orders of magnitude higher than 
PLO (e.g., albumin ~0.6 mmol/L, immunoglobulin 
G ~0.23 mmol/L). Compared to the results in PBS 
buffer, the inhibition effect was slightly milder, but 
still significant. At SWNT-OX concentrations equal 
to and above 20 nmol/L, complete inhibition of 
hemolysis was again observed. Serum proteins by 
themselves did not alter the hemolytic activity of 
PLO.
Using scanning electron microscopy (SEM), 
we closely examined the cell membranes of RBCs 
exposed to PLO alone, SWNT-OX alone, and PLO 
in the presence of SWNT-OX. In the SEM images, 
30–50 nm size pores formed by PLO in the absence 
of SWNT-OX were evident (Fig. 2(a)). In contrast, cell 
membranes of RBCs incubated with PLO (20 nmol/L) 
in the presence of SWNT-OX (10 nmol/L) in PBS 
buffer appeared smooth and intact (Fig. 2(b)), the 
same as those of control RBCs and RBCs exposed to 
SWNT-OX only (see ESM, Fig. S-1). The membranes 
of PLO-attacked cells can  also be seen to be evidently 
rougher in optical images of whole RBCs (Fig. 2 
insets). These observations confirmed that SWNTs 
prevented pore formation on cell membranes by 
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inhibiting the hemolytic activity of PLO. 
1.3 Cellular uptake of SWNT-OX by 
RBCs
We further studied cellular uptake 
of SWNT-OX by RBCs using Raman 
spectroscopy/imaging, and compared it 
with that by HeLa cells, a cell line which 
has been demonstrated in several 
l i t e r a t u re  re p o r t s  t o  i n t e r n a l i z e 
SWNTs efficiently [12]. HeLa cells and 
RBCs were incubated in SWNT-OX 
solutions under the same conditions 
(70 nmol/L SWNT-OX for 2 h at 37 °C). 
The strong Raman band at 1590 1600 cm–
1 called the tangential mode (or G band), 
which is caused by stretching along C
C bonds of graphene, was used as the 
signature to detect and map the presence 
of SWNT-OX inside cells or attached to 
cell membranes [4, 13]. Figure 3(a) shows 
a Raman image of a single HeLa cell, 
in which black color indicates locations 
with high G band intensity. Figure 
3(b) shows a typical Raman spectrum 
acquired in the middle of the cell region, 
which demonstrates clearly the uptake 
of SWNTs by HeLa cells. In contrast, 
no SWNT was observed inside or 
attached to RBCs (Fig. 3(c)), even though 
abundant SWNT-OX were present in 
the solution in which the RBCs were 
incubated (Fig. 3(c) inset). This result 
suggests that SWNT-OXs translocated 
into HeLa cells but not into RBCs, at least 
not at the levels observed for HeLa cells. 
RBCs are known to have lower endocytic 
activities than cancerous cell lines like 
HeLa, which could contribute to the 
lower or no cellular uptake of SWNT-OX 
by RBCs, since endocytosis is suggested 
to be one of the main trans-membrane 
mechanisms for SWNTs [14].
Figure 1 Microtitre hemolysis assay illustrating the effect of different concentrations 
of SWNT-OX on PLO activity in (a) 1×PBS buffer (pH 7.2) and (b) serum. Hemolysis of 




Figure 2 SEM images of the cell membranes of human RBCs exposed to (a) 20 
nmol/L PLO alone and (b) 20 nmol/L PLO plus 10 nmol/L SWNT-OX in PBS buffer. 
The arrows indicate the pores formed by PLO. Scale bars 500 nm. Insets are optical 
images of corresponding whole RBCs (scale bars 5 µm)
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1.4 Interactions of PLO with SWNT
PLO, in common with other CDCs, is secreted as 
soluble monomeric molecules. Upon binding to a 
cell membrane, PLO oligomerizes to form oligomeric 
pre-pores, which then insert into the lipid bilayer 
to form the final trans-membrane pores [15]. PLO 
consists of four domains. Domain 4 (PLO-D4), which 
contains the highly conserved tryptophan (Trp)-rich 
undecapeptide sequence, is believed to mediate the 
binding of PLO and some other CDCs to cholesterol-
containing membranes and has been shown to 
insert into cell membranes [16]. We suspected that 
the strong affinity of PLO-D4 for SWNT-OX could 
inactivate PLO in the solution phase and prevent 
PLO binding to the cell membrane. To test this 
hypothesis, we carried out molecular modeling and 
circular dichroism (CD) measurements. 
The predicted 3-D conformation of PLO-D4 (Fig. 
4(a)) indicates that the protein has a β-sheet-bundle 
structure. The CD spectrum of PLO-D4 in the “far-
UV” region (190 250 nm) also consistently suggested 
the abundant presence of β-sheet structures (Fig. 
4(b)). It is noteworthy that PLO-D4 has a total of 
nine Trp residues (positions 6, 8, 17, 35, 39, 71, 74, 75, 
and 101). Six of them are located on one end of the 
β-sheet-bundle where the protein surface is highly 
hydrophobic. Based on the 3-D homology model, 
Trp6, Trp8, Trp39, Trp71, Trp74, and Trp75 compose or 
are very close to a hydrophobic aromatic patch on the 
protein surface (Fig. 4(c)). It has been reported that 
aromatic molecules can interact strongly with CNTs 
[17]. Previous research has also shown the importance 
of Trp residues for peptide-nanotube interactions [18
20]. Therefore, a pristine (10, 10) SWNT (which does 
not contain side groups or defects) was manually 
docked into this area of PLO-D4 using Insight II to 
create a preliminary working model. This visually 
docked structure was then imported into the docking 
software program Molegro Virtual Docker. The 
default cavity detection algorithm of the program 
was utilized and a cavity created between the docked 
nanotube and the protein was used as the focus for 
the generation of a 25 Å radius binding site docking 
search with the following 17 residues in close 
proximity to the nanotube marked as fl exible for the 
docking process (Trp6, Trp8, Thr67, Gly68, Leu69, 
Ala70, Trp71, Asp72, Trp74, Trp75, Thr76, Asn79, 
Lys80, Thr97, Leu98, Asn99, and Pro100) (see ESM, 
Fig. S-2). Default conditions were used in the docking 
calculations and MolDock Score (Grid) was used as 
the scoring function for ranking the various docked 
poses of the nanotube with the protein model. The 
top 10 poses (lowest energies) were kept for analysis. 
The lowest energy docked structure from these 
calculations is shown in Fig. 4(d). This simulated 
interaction between PLO-D4 and SWNT supports the 
CD results for the protein titrated by SWNT-OX (Fig. 
4(b)), suggesting that the secondary structure of the 
protein is unaffected by binding to the nanotube. It is 
(a) (b) (c)
Figure 3 Raman spectroscopy/imaging studies of cellular uptake of SWNT-OX: (a) Raman image of a HeLa cell (color code: black, high G band 
intensity; scale bar 10 µm); (b) a typical Raman spectrum taken in the middle of the HeLa cell shown in (a); (c) Raman spectra taken from control 
human RBCs and RBCs after exposure to SWNT-OX under the same conditions as HeLa cells. (Inset) Raman spectrum taken from SWNT-OX 
solution in which human RBCs were incubated
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The effects of side groups and 
sur fac tants  on  the  PLO/SWNT 
binding were not considered in the 
molecular simulations, since surface 
coverages of surfactants or functional 
groups on both SWNT-OX and SWNT-
PEG are fairly low. According to 
the acid oxidation conditions, there 
are about seven COOH groups per 
thousand carbon atoms decorating the 
SWNT-OX sidewall [21]. In the case of 
SWNT-PEG, the percentage of surface 
area covered by PL-PEG is estimated 
to be about 10% [22]. Therefore, the 
intrinsic (non-functionalized) region 
of SWNT sidewall is anticipated to be 
dominant in interacting with proteins 
and peptides. 
2. Methods
2.1 Preparation of PLO and its 
domain 4 
Cultures (100 mL) of E. coli BL21 
carrying the pTrcHis B plasmid 
with  wi ld  type  PLO [23]   were 
grown in Luria Bertani (LB) broth 
(Bioshop, Burlington, Ontario) with 
ampicillin (100 μg/mL) at 37 °C. 
Once the OD650 reached 1, protein 
expression was induced with 1.0 
mmol/L isopropylthiogalactoside 
(IPTG), and incubation continued 
for another 3 h. Flasks of cells were 
then placed on an orbital shaker (150 
rpm) overnight at 25 °C. Cells were 
harvested by centrifugation at 500 
g for 10 min and the cell pellet was 
resuspended in column binding buffer 
(20 mmol/L Tris/HCl, 150 mmol/L 
NaCl, 10 mmol/L imidazole, pH 
8.0). The cells were lysed using an 
emulsifier (Avestin Emulsiflex-C5) at 
17,500 psi and the insoluble material 
was removed by centrifugation at 
(a) (b)
(c) (d)
Figure 4 Three-dimensional structure of PLO-D4 and its interaction with SWNT: (a) the 
homology model of the protein suggests a β-sheet-bundle structure; (b) CD spectra of 
PLO-D4 and mixtures of PLO-D4 and SWNT-OX with a molar ratio of 4:1 and 12:1; (c) stick 
model of PLO-D4 showing a hydrophobic aromatic patch on one end of the bundle (in the 
dashed circle) rich in Trp residues; (d) structure of PLO-D4 in the complex with the nanotube 
in surface view. (Color key: red, hydrophobic sites; blue, hydrophilic sites) 
Figure 5 AFM images of SWNT-OX before (a) and after (b) PLO-D4 adsorption. Scale 
bars 500 nm
likely that the pre-existence of a hydrophobic aromatic patch on the 
surface of PLO-D4 forms a native binding site for docking SWNT. 
High affi nity binding of PLO-D4 on SWNT-OX was also visualized 
using atomic force microscopy (Fig. 5).
(a) (b)
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12,000 g for 30 min. Histidine-tagged PLO was 
purifi ed from the soluble fraction by metal-chelating 
chromatography on Ni-nitrilotriacetic acid (NTA) 
agarose (Novagen, Oakville, Ontario), using a linear 
gradient of imidazole (10 450 mmol/L) in binding 
buffer for elution. The same protocol was followed 
for the purifi cation of PLO-D4.
2.2 Preparation of water soluble SWNTs
Two types of water soluble SWNTs were produced, 
namely, acid oxidized (SWNT-OX) and PL-PEG 
suspended (SWNT-PEG). In both cases, raw HipCo 
tubes (Carbon Nanotechnologies) were used as the 
starting material. A widely used method of acid 
oxidation was used to make SWNT-OX. The detailed 
protocol has been reported in a previous study [9]. To 
make SWNT-PEG, SWNT powder was sonicated in 1 
mg/mL PL-PEG (molecular mass 2805 g/mol, Avanti 
Polar Lipids) in deionized water for 1 h and then 
centrifuged (22,000 g, 6 h) to remove larger insoluble 
impurities. The physical dimensions and purity 
of SWNT-OX and SWNT-PEG were characterized 
using atomic force microscopy (AFM), scanning 
electron microscopy (SEM), and energy-dispersive 
analytical X-ray (EDAX) spectrometry. An AFM 
image of SWNT-OXs is shown in Fig. 5(a). Results 
us ing other  character izat ion methods were 
reported previously [9], and are therefore not 
presented here. UV vis NIR spectroscopy (with an 
extinction coefficient of 0.0079 (nmol/L)–1·cm–1 at 
808 nm) was used to determine the concentration 
of SWNTs in aqueous solutions [24].
2.3 Hemolysis assay
For the hemolysis assay, 400 μL of pelleted human 
erythrocytes (Cederlane) were washed four times 
in 1 ×PBS buffer (137 mmol/L NaCl, 2.7 mmol/L 
KCl, 10 mmol/L phosphate buffer, pH 7.3) by 
centrifugation. The erythrocytes (RBCs) were then 
resuspended in PBS buffer to 1% (v/v) [11]. Equal 
numbers of RBCs in PBS buffer were transferred 
into wells of a 96-well plate containing PLO and 
different concentrations of SWNTs either in 1 × PBS 
buffer or in 1 × FBS. The final concentration of PLO 
was kept the same (20 nmol/L) in all wells, except in 
the control with RBCs alone. Hemolytic activity was 
measured by the decrease in turbidity (OD650) using 
a 96-well plate reader (Specramax 190, Molecular 
Devices) at room temperature over a period of 2 h. 
Hemolytic titration was performed for SWNTs alone 
with RBCs, and for SWNTs plus PLO with RBCs. As 
a control, the turbidities of RBCs alone (no SWNTs, 
no PLO) and RBCs with wild type PLO (no SWNTs) 
were measured. The error bars indicate the standard 
deviations of fi ve replicates per treatment.
2.4 SEM sample preparation
High-resolution SEM (LEO FESEM 1530, Carl Zeiss 
SMT Inc.) was used to examine the cell membranes 
of human RBCs incubated in (1) 20 nmol/L PLO 
alone for 5 min, (2) 20 nmol/L PLO plus 10 nmol/L 
SWNT-OX for 2 h, and (3) incubated in 10 nmol/L 
SWNT-OX alone for 2 h. Incubation was carried 
out at room temperature. Control RBCs which 
had not been exposed to PLO or SWNTs were also 
imaged. Before fixation, the cells were washed 
four times with 1 × PBS buffer (pH 7.2) through 
filtration to remove free or loosely bound PLO or 
SWNTs. Finally, a standard SEM sample preparation 
procedure was followed [25].
2.5 Raman spectroscopy/imaging
Raman spectra were recorded with a LabRam HR 
system (HORIBA Jobin Yvon) equipped with an 
upright microscope and a piezo sample stage. Both 
HeLa cells and RBCs were incubated in 1×PBS buffer 
with an elevated SWNT-OX concentration (70 nmol/L) 
for 2 h at 37 ˚C. RBCs were then washed with 1×
PBS buffer and collected using centrifugation. The 
pellet of RBCs was then deposited and dried on a 
microscope slide. HeLa cells were directly cultured 
on a microscope slide and washed on the substrate 
with 1×PBS buffer at least four times. The Raman 
spectra were baseline corrected to remove the broad 
background Raman signal from cells and fixatives. 
For Raman imaging, cells were fixed following 
a standard procedure and the piezo stage was 
programmed to raster scan a 30 μm × 90 μm region 
with 1 μm step size.
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2.6 Circular dichroism measurements
Circular dichroism was performed on free and SWNT-
bound PLO-D4 using a Jasco J-715 spectropolarimeter 
(Easton, MD). Proteins were dissolved in 5 mmol/L 
K2HPO4 buffer (pH 7.2) at a concentration of 0.27 
μmol/L. The spectra were measured between 190 and 
250 nm as the average of 15 successive scans with a 
bandwidth of 1.0 nm and a scan speed of 20 nm/min. 
SWNT-OX and PLO-D4 were mixed and left at room 
temperature for 2 h to allow sufficient binding to 
take place. The molar ratios of PLO-D4 to SWNT-OX 
were 12:1 or 4:1. Note that we observed significant 
slowing down of PLO activity at those molar ratios in 
our hemolysis assay. We did not observe a CD signal 
from SWNT-OX alone.
2.7 Molecular modeling
The homology model of PLO-D4 was obtained using 
ESyPred3D program [26], and verified through 
energy minimization using the Discover_3 module in 
Accelrys Insight II software (Version 2005, San Diego, 
CA). An AMBER force fi eld, AMBER-99, was adopted, 
which was converted by the AmberFFC program [27]. 
The coordinates of SWNT presented in PDB format 
were generated with the Accelrys MS Studio program 
(San Diego, CA). The docking software program 
Molegro Virtual Docker [28] (MVD 2008.3.0.0; 
Molegro ApS, Denmark) was used to simulate the 
interaction between protein and nanotube. 
2.8 Atomic force microscopy (AFM)
To study PLO-D4 and SWNT-OX binding, they 
were mixed at a molar ratio of 10:1 in PBS for 2 h. 
The solution was then filtered through a 100 kDa 
molecular weight cut-off (MWCO) membrane to 
remove free and loosely bound PLO-D4 (15 kDa). The 
residue containing SWNT-OXs possibly loaded with 
PLO-D4 was then deposited on a silicon substrate 
and imaged using a Multimode Ⅲa Veeco atomic 
force microscope. For comparison, as-prepared 
SWNT-OXs were imaged at the same resolution.
3. Conclusions
Oxidized SWNTs have been shown to inhibit the 
activity of a pore-forming toxin, PLO. At a 1:1 molar 
ratio of SWNT-OX:PLO in serum,SWNT-OXs were 
able to completely inactivate trace amounts of PLO 
(20 nmol/L), which indicates that SWNT-OXs can act 
as a selective toxin sink. Molecular modeling results 
suggested that the Trp-rich hydrophobic domain 
of PLO has a high affinity for SWNTs in general 
[29], since the calculations did not involve specific 
functional side groups or surfactants. Besides SWNT-
OX, a different type of water soluble SWNT, SWNT-
PEG, was also tested (data available in the ESM, Fig. 
S-3) in order to demonstrate the generality of SWNTs 
as an antidote to PLO. Tight binding of SWNTs to 
domain 4 of PLO is believed to block the anchoring 
of PLO onto a cell membrane. It is anticipated that 
SWNTs will be able to function as a generic antidote 
to a wide variety of PFTs, since they have similar Trp 
residue-rich domains for lipid membrane binding. 
We did not observe any toxic effect of SWNT-OX 
and SWNT-PEG on human RBCs in this study. 
Furthermore, the Raman spectroscopic data indicated 
that it is very unlikely that SWNT-OX entered RBCs. 
No uptaken SWNT-OX was observed in RBCs even 
after exposure to a relatively high concentration of 
SWNT-OX solution. 
Future challenges in designing CNT detoxifi cation 
and drug delivery systems still remain. The blood 
circulation half-lives of current CNT carriers 
range from 0.5 to 3.5 h in mice [3, 6,30], which 
are significantly shorter than that of PEG-grafted 
liposomes (12 20 h in rats or mice, and 40 60 h in 
humans) [31]. While some reports have shown renal 
excretion of certain CNTs [6, 32, 33], there have also 
been others showing accumulation in organs such 
as liver, spleen, and kidney [3, 30, 34]. Although 
no acute or short mid term (up to four months) 
cytotoxic effects on the organs or the test subjects 
have been reported so far, the long term toxicity 
and immunogenicity of CNT carriers are unclear. 
Systematic investigation of the blood compatibility 
of CNT carriers remains to be completed. Finally, 
in order to use molecular modeling as an effective 
des ign tool ,  i t  wi l l  be  des irable  to  inc lude 
functional groups and surfactants in future CNT 
models, as well as to include mid–long distance 
interactions. 
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